-
2101por Accurso, Anthony J., Rastegar, Darius A., Ghazarian, Sharon R., Fingerhood, Michael I.“…BACKGROUND: The magnitude of the effect of hepatitis C viral infection on survival is still not fully understood. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2102por Castro, Rodolfo, Perazzo, Hugo, Grinsztejn, Beatriz, Veloso, Valdilea G., Hyde, Chris“…Moreover, the need of cost-effectiveness analysis in hepatitis C and the recent changes in treatment protocols were discussed.…”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2103por Santana, R.C., Machado, A.A., Martinelli, A.L.C., Jordão, A.A., Ramalho, L.N.Z., Vannucchi, H.“…A cross-sectional study was conducted in 43 non-cirrhotic patients with chronic hepatitis C to evaluate markers of vitamin A status represented by serum retinol, liver retinol, and serum retinol-binding protein levels. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2104por Westermann, Claudia, Peters, Claudia, Lisiak, Birgitte, Lamberti, Monica, Nienhaus, Albert“…The aim of this study was to estimate the prevalence of viral hepatitis C (HCV) infection among healthcare workers (HCWs) compared to the general population. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2105Next-Generation Sequencing Reveals Frequent Opportunities for Exposure to Hepatitis C Virus in Ghanapor Forbi, Joseph C., Layden, Jennifer E., Phillips, Richard O., Mora, Nallely, Xia, Guo-liang, Campo, David S., Purdy, Michael A., Dimitrova, Zoya E., Owusu, Dorcas O., Punkova, Lili T., Skums, Pavel, Owusu-Ofori, Shirley, Sarfo, Fred Stephen, Vaughan, Gilberto, Roh, Hajung, Opare-Sem, Ohene K., Cooper, Richard S., Khudyakov, Yury E.“…Globally, hepatitis C Virus (HCV) infection is responsible for a large proportion of persons with liver disease, including cancer. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2106por Eminler, Ahmet Tarik, Uslan, Mustafa Ihsan, Ayyildiz, Talat, Irak, Kader, Kiyici, Murat, Gurel, Selim, Dolar, Enver, Gulten, Macit, Nak, Selim Giray“…Two hundred and five chronic hepatitis B patients and 133 chronic hepatitis C patients who underwent liver biopsy were included in the study. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2107“…Background. Hepatitis C is a global major health problem with extremely variable extrahepatic manifestations. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2108por Lagging, Martin, Wejstål, Rune, Norkrans, Gunnar, Karlström, Olle, Aleman, Soo, Weiland, Ola, Castedal, Maria, Josephson, FilipEnlace del recurso
Publicado 2016
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2109por Cloherty, Gavin, Talal, Andrew, Coller, Kelly, Steinhart, Corklin, Hackett, John, Dawson, George, Rockstroh, Juergen, Feld, Jordan“…The drugs available for the treatment of hepatitis C virus (HCV) have evolved to provide shorter treatment duration and higher rates of sustained virologic response (SVR), and the role of HCV infection diagnostic tests has had to evolve in order to meet changing clinical needs. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2110por He, Shanshan, Xiao, Jingbo, Dulcey, Andrés E., Lin, Billy, Rolt, Adam, Hu, Zongyi, Hu, Xin, Wang, Amy Q., Xu, Xin, Southall, Noel, Ferrer, Marc, Zheng, Wei, Liang, T. Jake, Marugan, Juan J.“…The optimized molecules can serve as lead preclinical candidates for the treatment of hepatitis C virus infection and as probes to study hepatitis C virus pathogenesis and host–virus interaction.…”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2111“…Engagement of individuals infected with hepatitis C virus (HCV) with care pathways remains a major barrier to realizing the benefits of new and more effective antiviral therapies. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2112por Arrayhani, Mohamed, Sqalli, Tarik, Tazi, Nada, El Youbi, Randa, Chaouch, Safae, Aqodad, Nourdin, Ibrahimi, Sidi Adil“…Cross-sectional study including all chronic hemodialysis patients with hepatitis C virus, in two public hemodialysis centers of Fez. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2113“…Therefore, testing for hepatitis B surface antigen (HBsAg), antibodies to hepatitis B core antigen (anti-HBc) and antibodies to hepatitis C antigen (anti-HCV) is a very important preventative measure. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2114por Younossi, Zobair M., Stepanova, Maria, Chan, Henry L.Y., Lee, Mei H., Yu, Ming-Lung, Dan, Yock Y., Choi, Moon S., Henry, Linda“…Prevalence of chronic hepatitis C (CH-C) infection in patients of Asian ancestry ranges between 1% and 20%. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2115por Kelly, Christabel, Swadling, Leo, Brown, Anthony, Capone, Stefania, Folgori, Antonella, Salio, Mariolina, Klenerman, Paul, Barnes, Eleanor“…Viral diversity is a challenge to the development of a hepatitis C virus (HCV) vaccine. Following vaccination of humans with adenoviral vectors, we determined the capacity of T cells to target common viral variants at immundominant epitopes ex vivo. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2116por Álvaro-Meca, Alejandro, Jiménez-Sousa, María A., Boyer, Alexandre, Medrano, José, Reulen, Holger, Kneib, Thomas, Resino, Salvador“…BACKGROUND: Cirrhosis and severe sepsis are factors associated with increased mortality in intensive care unit (ICU), but chronic hepatitis C (CHC) has been less studied in ICU. The aim of this study was to analyze the impact of CHC on the mortality of cirrhotic patients admitted to ICU according to severe sepsis and decompensated cirrhosis. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2117por Kanellopoulou, Theoni, Alexopoulou, Alexandra, Kontopidou, Flora N., Konstantinides, Polydoros, Papatheodoridis, George V.“…BACKGROUND: Platelet microparticles (PMPs) are platelet-derived membrane vesicles involved in cardiovascular diseases and atherosclerosis. Chronic hepatitis C (CHC) is associated with increased atherosclerosis, but the effect of therapy on its atherogenic potential has not been adequately studied. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2118por Tama, Maher, Naylor, Paul, Patel, Suhag, Altawil, Johnny, Gulati, Dhiraj, Antaki, Fadi, Mutchnick, Milton G., Ehrinpreis, Murray“…Background: Evaluation of advanced fibrosis in patients with hepatitis C virus (HCV) infection is used to facilitate decisions on treatment strategy and to initiate additional screening measures. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2119
-
2120por Kelly, Christabel, Swadling, Leo, Capone, Stefania, Brown, Anthony, Richardson, Rachel, Halliday, John, von Delft, Annette, Oo, Ye, Mutimer, David, Kurioka, Ayako, Hartnell, Felicity, Collier, Jane, Ammendola, Virginia, Sorbo, Mariarosaria Del, Grazioli, Fabiana, Esposito, Maria Luisa, Marco, Stefania Di, Siani, Loredana, Traboni, Cinzia, Hill, Adrian V.S., Colloca, Stefano, Nicosia, Alfredo, Cortese, Riccardo, Folgori, Antonella, Klenerman, Paul, Barnes, Eleanor“…Adenoviral vectors encoding hepatitis C virus (HCV) nonstructural (NS) proteins induce multispecific, high‐magnitude, durable CD4(+) and CD8(+) T‐cell responses in healthy volunteers. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto